开云app官网登录入口网页版-官方正版

#SSc#

21篇内容 | 1580人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2186568, encodeId=e4092186568e6, content=<a href='/topic/show?id=787ae6923db' target=_blank style='color:#2F92EE;'>#系统性硬化症#</a> <a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a> <a href='/topic/show?id=5d3de78706d' target=_blank style='color:#2F92EE;'>#细胞外基质#</a>, objectTitle=文献速递 | 探索系统性硬化症：细胞外基质的奥秘与治疗前景, objectType=article, longId=805726, objectId=7a71805e2685, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=7a71805e2685, replyNumber=0, likeNumber=71, createdTime=2024-02-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=7a71805e2685, moduleTitle=文献速递 | 探索系统性硬化症：细胞外基质的奥秘与治疗前景, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7a71805e2685)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1587702, encodeId=e9cd158e702c5, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=AJRCCM：B细胞去除治疗系统性硬化症相关性肺动脉高压(SSC-PAH)的安全性和有效性, objectType=article, longId=218717, objectId=b364218e1739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b364218e1739, replyNumber=0, likeNumber=67, createdTime=2021-10-18, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b364218e1739, moduleTitle=AJRCCM：B细胞去除治疗系统性硬化症相关性肺动脉高压(SSC-PAH)的安全性和有效性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b364218e1739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587701, encodeId=6897158e7010b, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Radiology：SSc相关性ILD的评价，我们又近了一步, objectType=article, longId=214830, objectId=c3e621483030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3e621483030, replyNumber=0, likeNumber=75, createdTime=2021-07-27, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3e621483030, moduleTitle=Radiology：SSc相关性ILD的评价，我们又近了一步, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c3e621483030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587700, encodeId=fb97158e700e1, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Arthritis Rheumatol：早期弥漫性皮肤SSc患者间质性肺病的肺功能检查, objectType=article, longId=196609, objectId=4f071966092f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f071966092f, replyNumber=0, likeNumber=53, createdTime=2020-06-29, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f071966092f, moduleTitle=Arthritis Rheumatol：早期弥漫性皮肤SSc患者间质性肺病的肺功能检查, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4f071966092f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587699, encodeId=80f4158e69977, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Ann Rheum Dis：早期弥漫性皮肤SSc的皮肤基因表达分析显示明显的先天和适应性炎症, objectType=article, longId=183646, objectId=7a74183646ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a74183646ca, replyNumber=0, likeNumber=71, createdTime=2019-11-28, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a74183646ca, moduleTitle=Ann Rheum Dis：早期弥漫性皮肤SSc的皮肤基因表达分析显示明显的先天和适应性炎症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7a74183646ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587698, encodeId=10e0158e69806, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=2019 ESsCD指南：乳糜泻和其他麸质相关疾病, objectType=article, longId=172205, objectId=0ed51e22059c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ed51e22059c, replyNumber=0, likeNumber=50, createdTime=2019-06-27, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ed51e22059c, moduleTitle=2019 ESsCD指南：乳糜泻和其他麸质相关疾病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0ed51e22059c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587697, encodeId=3dcc158e697c6, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=J Rheumatol：伴胃食管反流的SSc患者中患者报告结局指标的纵向评估, objectType=article, longId=153765, objectId=5954153e65d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5954153e65d0, replyNumber=0, likeNumber=103, createdTime=2018-11-19, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5954153e65d0, moduleTitle=J Rheumatol：伴胃食管反流的SSc患者中患者报告结局指标的纵向评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5954153e65d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587696, encodeId=c8fb158e69667, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Arthritis Rheumatol:糖皮质激素和环磷酰胺给男性SLE或SSc患者会心一击, objectType=article, longId=107429, objectId=83b210e429f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83b210e429f1, replyNumber=0, likeNumber=64, createdTime=2017-08-03, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83b210e429f1, moduleTitle=Arthritis Rheumatol:糖皮质激素和环磷酰胺给男性SLE或SSc患者会心一击, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=83b210e429f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587695, encodeId=7295158e695b5, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Arthritis Rheumatol：循环CCL-2预测早期SSc患者ILD的长期进展！, objectType=article, longId=100757, objectId=a556100e57c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a556100e57c3, replyNumber=0, likeNumber=71, createdTime=2017-06-07, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a556100e57c3, moduleTitle=Arthritis Rheumatol：循环CCL-2预测早期SSc患者ILD的长期进展！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a556100e57c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587694, encodeId=aec2158e694b2, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Arthritis Rheumatol：pDCs中miR-618的表达与SSc患者的频率和活化改变相关！, objectType=article, longId=100109, objectId=f503100109df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f503100109df, replyNumber=0, likeNumber=79, createdTime=2017-05-31, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f503100109df, moduleTitle=Arthritis Rheumatol：pDCs中miR-618的表达与SSc患者的频率和活化改变相关！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f503100109df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587693, encodeId=d268158e69387, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=同济学报被踢出CSSCI“核心期刊” 学报主编怒斥“潜规则”, objectType=article, longId=87930, objectId=57ab8e930bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57ab8e930bb, replyNumber=0, likeNumber=60, createdTime=2017-01-22, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57ab8e930bb, moduleTitle=同济学报被踢出CSSCI“核心期刊” 学报主编怒斥“潜规则”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=57ab8e930bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587692, encodeId=8eef158e692c6, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=勃林格血管激酶抑制剂Ofev（nintedanib）在欧美喜获治疗系统性硬化症（SSc）的孤儿药地位, objectType=article, longId=77494, objectId=d3b3e749422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3b3e749422, replyNumber=0, likeNumber=46, createdTime=2016-09-16, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3b3e749422, moduleTitle=勃林格血管激酶抑制剂Ofev（nintedanib）在欧美喜获治疗系统性硬化症（SSc）的孤儿药地位, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d3b3e749422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587691, encodeId=ce6b158e691cd, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=投文章前，先搞清SCI、EI、ISTP、SSCI、CSSCI和CSCD吧！, objectType=article, longId=51750, objectId=333851e5032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=333851e5032, replyNumber=0, likeNumber=84, createdTime=2015-06-07, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=333851e5032, moduleTitle=投文章前，先搞清SCI、EI、ISTP、SSCI、CSSCI和CSCD吧！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=333851e5032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587690, encodeId=e567158e6900e, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Arthritis Care Res：SSc患者的疼痛与疾病严重程度不完全相符, objectType=article, longId=38659, objectId=7e7638659df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e7638659df, replyNumber=0, likeNumber=76, createdTime=2014-08-07, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e7638659df, moduleTitle=Arthritis Care Res：SSc患者的疼痛与疾病严重程度不完全相符, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7e7638659df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587689, encodeId=9861158e689a6, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=2012年SCI/SSCI新收录中国大陆期刊汇总与简析, objectType=article, longId=13997, objectId=0a5f1399e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a5f1399e54, replyNumber=0, likeNumber=63, createdTime=2013-01-07, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a5f1399e54, moduleTitle=2012年SCI/SSCI新收录中国大陆期刊汇总与简析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0a5f1399e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587688, encodeId=2752158e6881b, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=Rheumatology：近40年间SSc死亡率无下降趋势, objectType=article, longId=10154, objectId=34ca10154c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ca10154c1, replyNumber=0, likeNumber=71, createdTime=2012-10-10, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ca10154c1, moduleTitle=Rheumatology：近40年间SSc死亡率无下降趋势, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=34ca10154c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587687, encodeId=be80158e687a1, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=CrossCheck反剽窃文献检测系统报告实例及简介, objectType=article, longId=7311, objectId=341ae311ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=341ae311ea, replyNumber=0, likeNumber=62, createdTime=2012-06-25, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=341ae311ea, moduleTitle=CrossCheck反剽窃文献检测系统报告实例及简介, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=341ae311ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587686, encodeId=5bf6158e68682, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=ISSCR:国际干细胞研究学会年会发布两项重要成果, objectType=article, longId=7261, objectId=802ee261d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=802ee261d2, replyNumber=0, likeNumber=74, createdTime=2012-06-22, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=802ee261d2, moduleTitle=ISSCR:国际干细胞研究学会年会发布两项重要成果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=802ee261d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587685, encodeId=4b44158e68571, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=如何向SSCI投稿？, objectType=article, longId=549, objectId=3a0754942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0754942, replyNumber=0, likeNumber=65, createdTime=2010-07-16, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0754942, moduleTitle=如何向SSCI投稿？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3a0754942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587684, encodeId=34e7158e6840f, content=<a href='/topic/show?id=17f616e061e' target=_blank style='color:#2F92EE;'>#SSc#</a>, objectTitle=SSCI是什么？它的期刊目录有哪些？, objectType=article, longId=276, objectId=362b2e6c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=362b2e6c7, replyNumber=0, likeNumber=69, createdTime=2009-12-28, rootId=0, userName=lujian, userId=cfe317553921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=362b2e6c7, moduleTitle=SSCI是什么？它的期刊目录有哪些？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=362b2e6c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

SSc

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#系统性硬化症# #SSc# #细胞外基质#

文献速递 | 探索系统性硬化症：细胞外基质的奥秘与治疗前景

2024-02-08发表于陕西省

lujian (审核中...)

前往app查看评论内容

#SSc#

AJRCCM：B细胞去除治疗系统性硬化症相关性肺动脉高压(SSC-PAH)的安全性和有效性

2021-10-18

lujian (审核中...)

前往app查看评论内容

#SSc#

Radiology：SSc相关性ILD的评价，我们又近了一步

2021-07-27

lujian (审核中...)

前往app查看评论内容

#SSc#

Arthritis Rheumatol：早期弥漫性皮肤SSc患者间质性肺病的肺功能检查

2020-06-29

lujian (审核中...)

前往app查看评论内容

#SSc#

Ann Rheum Dis：早期弥漫性皮肤SSc的皮肤基因表达分析显示明显的先天和适应性炎症

2019-11-28

lujian (审核中...)

前往app查看评论内容

#SSc#

2019 ESsCD指南：乳糜泻和其他麸质相关疾病

2019-06-27

lujian (审核中...)

前往app查看评论内容

#SSc#

J Rheumatol：伴胃食管反流的SSc患者中患者报告结局指标的纵向评估

2018-11-19

lujian (审核中...)

前往app查看评论内容

#SSc#

Arthritis Rheumatol:糖皮质激素和环磷酰胺给男性SLE或SSc患者会心一击

2017-08-03

lujian (审核中...)

前往app查看评论内容

#SSc#

Arthritis Rheumatol：循环CCL-2预测早期SSc患者ILD的长期进展！

2017-06-07

lujian (审核中...)

前往app查看评论内容

#SSc#

Arthritis Rheumatol：pDCs中miR-618的表达与SSc患者的频率和活化改变相关！

2017-05-31

lujian (审核中...)

前往app查看评论内容

#SSc#

同济学报被踢出CSSCI“核心期刊” 学报主编怒斥“潜规则”

2017-01-22

lujian (审核中...)

前往app查看评论内容

#SSc#

勃林格血管激酶抑制剂Ofev（nintedanib）在欧美喜获治疗系统性硬化症（SSc）的孤儿药地位

2016-09-16

lujian (审核中...)

前往app查看评论内容

#SSc#

投文章前，先搞清SCI、EI、ISTP、SSCI、CSSCI和CSCD吧！

2015-06-07

lujian (审核中...)

前往app查看评论内容

#SSc#

Arthritis Care Res：SSc患者的疼痛与疾病严重程度不完全相符

2014-08-07

lujian (审核中...)

前往app查看评论内容

#SSc#

2012年SCI/SSCI新收录中国大陆期刊汇总与简析

2013-01-07

lujian (审核中...)

前往app查看评论内容

#SSc#

Rheumatology：近40年间SSc死亡率无下降趋势

2012-10-10

lujian (审核中...)

前往app查看评论内容

#SSc#

CrossCheck反剽窃文献检测系统报告实例及简介

2012-06-25

lujian (审核中...)

前往app查看评论内容

#SSc#

ISSCR:国际干细胞研究学会年会发布两项重要成果

2012-06-22

lujian (审核中...)

前往app查看评论内容

#SSc#

如何向SSCI投稿？

2010-07-16

lujian (审核中...)

前往app查看评论内容

#SSc#

SSCI是什么？它的期刊目录有哪些？

2009-12-28

科室
- - 订阅+
  - 更多科室
工具
服务